Argo Blockchain
ARBK
Abits
ABTS
The9 Ltd
NCTY
4
BIT Mining
BTCM
5
Coinbase
COIN
US Stock MarketDetailed Quotes
OLMA Olema Pharmaceuticals
- 4.310
- -0.370-7.91%
Trading May 14 13:22 ET
294.90MMarket Cap-2.16P/E (TTM)
5.080High4.060Low449.66KVolume5.080Open4.680Pre Close1.96MTurnover1.09%Turnover RatioLossP/E (Static)68.42MShares16.62052wk High0.77P/B177.55MFloat Cap2.86052wk Low--Dividend TTM41.19MShs Float60.270Historical High--Div YieldTTM21.80%Amplitude2.000Historical Low4.349Avg Price1Lot Size
Olema Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -87.18%-43.98M | -24.63%-104.35M | -42.26%-26.28M | -18.78%-27.02M | -24.59%-27.56M | -15.23%-23.5M | -2.03%-83.73M | 6.27%-18.48M | -26.41%-22.74M | 16.41%-22.12M |
| Net income from continuing operations | 1.88%-30.39M | -33.95%-129.47M | -25.38%-33.57M | -60.71%-34.56M | -51.19%-30.38M | -9.49%-30.97M | 7.76%-96.66M | -2.27%-26.77M | 5.36%-21.5M | 38.84%-20.1M |
| Operating gains losses | ---- | -91.89%9K | ---- | ---- | ---- | ---- | --111K | --0 | --103K | ---- |
| Depreciation and amortization | 45.45%128K | 4.24%393K | 31.82%116K | 5.56%95K | -5.05%94K | -12.00%88K | 5.60%377K | -9.28%88K | -1.10%90K | 16.47%99K |
| Other non cash items | 12.24%-1.81M | -66.19%-7.03M | -51.69%-7.89M | -10.00%288K | 121.09%2.64M | -281.37%-2.07M | -922.37%-4.23M | -1,027.98%-5.2M | -2.14%320K | 267.69%1.2M |
| Change In working capital | -458.32%-16.28M | 1,655.86%9.16M | -62.51%2.18M | 177.11%3.53M | 80.31%-1.09M | 22.58%4.54M | -119.49%-589K | 230.71%5.8M | -2,135.11%-4.58M | -526.99%-5.52M |
| -Change in prepaid assets | -65.54%549K | -161.82%-429K | -574.81%-1.9M | -23.33%-148K | 104.82%30K | 53.91%1.59M | 135.43%694K | 119.85%401K | 16.08%-120K | -2,043.75%-622K |
| -Change in payables and accrued expense | -186.91%-4.31M | 8.00%2.51M | 413.85%2.52M | -386.77%-1.67M | -449.79%-3.3M | 1,514.98%4.96M | 562.11%2.32M | 36.39%491K | 649.06%582K | 737.84%944K |
| -Change in other current assets | 28.15%-965K | 44.46%-2.96M | -9,300.00%-368K | 96.79%-167K | -711.28%-1.08M | ---1.34M | -377.92%-5.32M | --4K | -808.22%-5.2M | 55.96%-133K |
| -Change in other current liabilities | -1,640.51%-11.56M | 484.74%10.04M | -60.78%1.93M | 3,481.17%5.52M | 157.16%3.26M | -128.08%-664K | -70.11%1.72M | 43.72%4.91M | -85.28%154K | -433.72%-5.71M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -87.18%-43.98M | -24.63%-104.35M | -42.26%-26.28M | -18.78%-27.02M | -24.59%-27.56M | -15.23%-23.5M | -2.03%-83.73M | 6.27%-18.48M | -26.41%-22.74M | 16.41%-22.12M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -123.80%-45.08M | -1,827.97%-93.53M | -270.12%-114.42M | 280.53%45.92M | -134.56%-4.88M | -153.88%-20.14M | -105.30%-4.85M | -289.24%-30.92M | -226.15%-25.44M | -52.02%14.11M |
| Net PPE purchase and sale | --0 | -1,235.71%-159K | --0 | --0 | ---6K | ---153K | 103.86%14K | --0 | 110.07%14K | --0 |
| Net investment purchase and sale | -125.52%-45.08M | -1,819.16%-93.37M | -270.12%-114.42M | 280.43%45.92M | -134.52%-4.87M | -153.47%-19.99M | -105.30%-4.87M | -287.26%-30.92M | -225.35%-25.45M | -52.05%14.11M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -123.80%-45.08M | -1,827.97%-93.53M | -270.12%-114.42M | 280.53%45.92M | -134.56%-4.88M | -153.88%-20.14M | -105.30%-4.85M | -289.24%-30.92M | -226.15%-25.44M | -52.02%14.11M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -97.48%222K | 101.49%268.82M | 46,611.28%244.3M | -99.93%92K | 663.83%15.61M | 3,909.55%8.82M | 27,928.36%133.42M | 91.58%523K | 123,134.91%130.63M | 3,092.19%2.04M |
| Net common stock issuance | --0 | 105.25%266.29M | 1,014,687.50%243.5M | --0 | --14.89M | --7.9M | --129.74M | ---24K | --129.76M | --0 |
| Proceeds from stock option exercised by employees | -74.35%236K | -31.23%2.53M | 46.07%799K | -89.41%92K | -64.81%719K | 318.18%920K | 672.90%3.68M | 100.37%547K | 719.81%869K | 3,092.19%2.04M |
| Net other financing activities | ---14K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -97.48%222K | 101.49%268.82M | 46,611.28%244.3M | -99.93%92K | 663.83%15.61M | 3,909.55%8.82M | 27,928.36%133.42M | 91.58%523K | 123,134.91%130.63M | 3,092.19%2.04M |
| Net cash flow | ||||||||||
| Beginning cash position | 103.50%139.48M | 189.17%68.54M | -69.43%35.89M | -51.68%16.89M | -17.59%33.72M | 189.17%68.54M | 71.60%23.7M | 338.02%117.41M | 42.53%34.96M | 90.24%40.92M |
| Current changes in cash | -155.15%-88.84M | 58.22%70.94M | 311.98%103.59M | -76.96%19M | -182.35%-16.83M | -302.25%-34.82M | 353.36%44.84M | -1,475.37%-48.87M | 3,519.36%82.45M | -297.55%-5.96M |
| End cash Position | 50.18%50.64M | 103.50%139.48M | 103.50%139.48M | -69.43%35.89M | -51.68%16.89M | -17.59%33.72M | 189.17%68.54M | 189.17%68.54M | 338.02%117.41M | 42.53%34.96M |
| Free cash flow | -85.97%-43.98M | -24.82%-104.51M | -42.26%-26.28M | -18.78%-27.02M | -24.62%-27.56M | -15.98%-23.65M | -1.58%-83.73M | 7.08%-18.48M | -25.44%-22.74M | 16.48%-22.12M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Market Insights
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025